Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Member of the Ampakine class of memory enhancers prolongs the single channel open time of reconstituted AMPA receptors.

Suppiramaniam V, Bahr BA, Sinnarajah S, Owens K, Rogers G, Yilma S, Vodyanoy V.

Synapse. 2001 May;40(2):154-8.

PMID:
11252027
2.
3.

1-BCP, a memory-enhancing agent, selectively potentiates AMPA-induced [3H]norepinephrine release in rat hippocampal slices.

Desai MA, Valli MJ, Monn JA, Schoepp DD.

Neuropharmacology. 1995 Feb;34(2):141-7.

PMID:
7542369
4.
6.

Modulatory effects of dextran sulfate and fucoidan on binding and channel properties of AMPA receptors isolated from rat brain.

Suppiramaniam V, Vaithianathan T, Manivannan K, Dhanasekaran M, Parameshwaran K, Bahr BA.

Synapse. 2006 Nov;60(6):456-64.

PMID:
16897725
7.

Memory and the brain: unexpected chemistries and a new pharmacology.

Lynch G.

Neurobiol Learn Mem. 1998 Jul-Sep;70(1-2):82-100. Review.

PMID:
9753589
8.

LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.

Murray TK, Whalley K, Robinson CS, Ward MA, Hicks CA, Lodge D, Vandergriff JL, Baumbarger P, Siuda E, Gates M, Ogden AM, Skolnick P, Zimmerman DM, Nisenbaum ES, Bleakman D, O'Neill MJ.

J Pharmacol Exp Ther. 2003 Aug;306(2):752-62. Epub 2003 May 2.

9.

Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action.

Arai AC, Xia YF, Rogers G, Lynch G, Kessler M.

J Pharmacol Exp Ther. 2002 Dec;303(3):1075-85.

10.

Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation.

Kanju PM, Parameshwaran K, Sims C, Bahr BA, Shonesy BC, Suppiramaniam V.

Exp Neurol. 2008 Nov;214(1):55-61. doi: 10.1016/j.expneurol.2008.07.010. Epub 2008 Jul 18.

PMID:
18687330
12.

Single channel recordings from synaptosomal AMPA receptors.

Vaithianathan T, Manivannan K, Kleene R, Bahr BA, Dey MP, Dityatev A, Suppiramaniam V.

Cell Biochem Biophys. 2005;42(1):75-85.

PMID:
15673930
13.

Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546.

Nagarajan N, Quast C, Boxall AR, Shahid M, Rosenmund C.

Neuropharmacology. 2001 Nov;41(6):650-63.

PMID:
11640919
14.
16.

Differential modulation of the GYKI 53784-induced inhibition of AMPA currents by various AMPA-positive modulators in cerebellar Purkinje cells.

Kapus G, Bódi I, Pataki A, Gueritaud J, Székely JI, Tarnawa I.

Eur J Pharmacol. 2000 May 26;397(1):43-7.

PMID:
10844097
17.

Excitatory amino acids and neuronal plasticity: modulation of AMPA receptors as a novel substrate for the action of nootropic drugs.

Nicoletti F, Casabona G, Genazzani AA, Copani A, Aleppo G, Canonico PL, Scapagnini U.

Funct Neurol. 1992 Sep-Oct;7(5):413-22. Review.

PMID:
1338053
19.

Synergistic interactions between ampakines and antipsychotic drugs.

Johnson SA, Luu NT, Herbst TA, Knapp R, Lutz D, Arai A, Rogers GA, Lynch G.

J Pharmacol Exp Ther. 1999 Apr;289(1):392-7.

20.

Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function.

Parameshwaran K, Sims C, Kanju P, Vaithianathan T, Shonesy BC, Dhanasekaran M, Bahr BA, Suppiramaniam V.

Synapse. 2007 Jun;61(6):367-74.

PMID:
17372971

Supplemental Content

Support Center